HANSON; Gunnar J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for HANSON; Gunnar J..The latest application filed is for "exon skipping oligomer conjugates for muscular dystrophy".

Company Profile

21.69.88

HANSON; Gunnar J. - Cambridge MA
Hanson; Gunnar J. - Bothell WA
Hanson; Gunnar J. - Dallas TX US
Hanson; Gunnar J. - Chapel Hill NC
Hanson; Gunnar J. - Skokie IL
Hanson, Gunnar J. - Durham NC
HANSON, GUNNAR J - SKOKIE IL
HANSON, GUNNAR J. - STOKIE IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Exon Skipping Oligomer Conjugates For Muscular Dystrophy App 20220280546 - PASSINI; Marco A. ; et al.	2022-09-08
Exon skipping oligomer conjugates for muscular dystrophy Grant 11,395,855 - Passini , et al. July 26, 2	2022-07-26
Exon skipping oligomer conjugates for muscular dystrophy Grant 11,382,981 - Passini , et al. July 12, 2	2022-07-12
Exon skipping oligomer conjugates for muscular dystrophy Grant 11,338,041 - Hanson , et al. May 24, 2	2022-05-24
Functionally-Modified Oligonucleotides And Subunits Thereof App 20220127613 - Hanson; Gunnar J. ; et al.	2022-04-28
Peptide Oligonucleotide Conjugates App 20220072143 - Hanson; Gunnar J. ; et al.	2022-03-10
Peptide oligonucleotide conjugates Grant 11,225,662 - Hanson January 18, 2	2022-01-18
Compound And Method For Treating Myotonic Dystrophy App 20220002733 - Hanson; Gunnar J. ; et al.	2022-01-06
Functionally-modified oligonucleotides and subunits thereof Grant 11,208,655 - Hanson , et al. December 28, 2	2021-12-28
Exon Skipping Oligomer Conjugates For Muscular Dystrophy App 20210338830 - PASSINI; Marco A. ; et al.	2021-11-04
Trimeric Peptides For Antisense Delivery App 20210290772 - Wolfe; Justin ; et al.	2021-09-23
Methods And Compounds For Treatment Of Lymphocyte-related Diseases And Conditions App 20210283170 - Mourich; Dan V. ; et al.	2021-09-16
Chimeric Peptides For Antisense Deliver App 20210260206 - PENTELUTE; Bradley L. ; et al.	2021-08-26
Peptide oligonucleotide conjugates Grant 11,097,011 - Hanson , et al. August 24, 2	2021-08-24
Exon Skipping Oligomer Conjugates For Muscular Dystrophy App 20210169919 - Passini; Marco A. ; et al.	2021-06-10
Modified Antisense Oligomers For Exon Inclusion In Spinal Muscular Atrophy App 20210169918 - Passini; Marco A. ; et al.	2021-06-10
Methods and compounds for treatment of lymphocyte-related diseases and conditions Grant 11,020,417 - Mourich , et al. June 1, 2	2021-06-01
Oligonucleotide Analogues Having Modified Intersubunit Linkages And/or Terminal Groups App 20210139897 - Hanson; Gunnar J. ; et al.	2021-05-13
Peptide Oligonucleotide Conjugates App 20210139896 - Hanson; Gunnar J.	2021-05-13
Exon Skipping Oligomer Conjugates For Muscular Dystrophy App 20210138079 - HANSON; Gunnar J. ; et al.	2021-05-13
Exon skipping oligomer conjugates for muscular dystrophy Grant 11,000,600 - Passini , et al. May 11, 2	2021-05-11
Exon Skipping Oligomer Conjugates For Muscular Dystropy App 20210077628 - PASSINI; Marco A. ; et al.	2021-03-18
Compound and method for treating myotonic dystrophy Grant 10,927,378 - Kole , et al. February 23, 2	2021-02-23
Modified antisense oligomers for exon inclusion in spinal muscular atrophy Grant 10,905,709 - Passini , et al. February 2, 2	2021-02-02
Exon skipping oligomer conjugates for muscular dystrophy Grant 10,888,578 - Passini , et al. January 12, 2	2021-01-12
Exon Skipping Oligomer Conjugates For Muscular Dystrophy App 20200377886 - PASSINI; Marco A. ; et al.	2020-12-03
Processes For Preparing Phosphorodiamidate Morpholino Oligomers Via Fast-flow Synthesis App 20200362339 - Totaro; Kyle A. ; et al.	2020-11-19
Cell-Penetrating Peptides For Antisense Delivery App 20200316210 - Wolfe; Justin M. ; et al.	2020-10-08
Exon skipping oligomer conjugates for muscular dystrophy Grant 10,765,760 - Hanson , et al. Sep	2020-09-08
Peptide Oligonucleotide Conjugates App 20200277598 - Hanson; Gunnar J.	2020-09-03
Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups Grant 10,760,078 - Hanson , et al. Sep	2020-09-01
Peptide Oligonucleotide Conjugates App 20200254109 - Kind Code	2020-08-13
Bicyclic Peptide Oligonucleotide Conjugates App 20200237922 - Wolfe; Justin M. ; et al.	2020-07-30
Peptide oligonucleotide conjugates Grant 10,675,356 - Hanson , et al.	2020-06-09
Functionally-Modified Oligonucleotides And Subunits Thereof App 20200115709 - Hanson; Gunnar J. ; et al.	2020-04-16
Exon Skipping Oligomer Conjugates For Muscular Dystrophy App 20200078465 - PASSINI; Marco A. ; et al.	2020-03-12
Exon Skipping Oligomer Conjugates For Muscular Dystrophy App 20190365919 - Hanson; Gunnar J. ; et al.	2019-12-05
Peptide oligonucleotide conjugates Grant 10,487,326 - Hanson Nov	2019-11-26
Compound And Method For Treating Myotonic Dystrophy App 20190264210 - Kole; Ryszard ; et al.	2019-08-29
Oligonucleotide Analogues Having Modified Intersubunit Linkages And/or Terminal Groups App 20190218551 - Hanson; Gunnar J. ; et al.	2019-07-18
Functionally-modified oligonucleotides and subunits thereof Grant 10,344,281 - Hanson , et al. July 9, 2	2019-07-09
Oligonucleotides For Treating Expanded Repeat Diseases App 20190100755 - Linsley; Peter ; et al.	2019-04-04
Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups Grant 10,202,602 - Hanson , et al. Feb	2019-02-12
Peptide Oligonucleotide Conjugates App 20190030176 - Hanson; Gunnar J. ; et al.	2019-01-31
Modified Antisense Oligomers For Exon Inclusion In Spinal Muscular Atrophy App 20190015440 - Passini; Marco A. ; et al.	2019-01-17
Compound and method for treating myotonic dystrophy Grant 10,106,796 - Kole , et al. October 23, 2	2018-10-23
Peptide Oligonucleotide Conjugates App 20180298383 - Hanson; Gunnar J.	2018-10-18
Exon Skipping Oligomer Conjugates For Muscular Dystrophy App 20180271993 - PASSINI; Marco A. ; et al.	2018-09-27
Oligonucleotides for treating expanded repeat diseases Grant 10,066,228 - Linsley , et al. September 4, 2	2018-09-04
Functionally-Modified Oligonucleotides And Subunits Thereof App 20180223278 - Hanson; Gunnar J. ; et al.	2018-08-09
Peptide Oligonucleotide Conjugates App 20180214567 - Hanson; Gunnar J. ; et al.	2018-08-02
Exon Skipping Oligomer Conjugates For Muscular Dystrophy App 20180177814 - PASSINI; Marco A. ; et al.	2018-06-28
Methods And Compounds For Treatment Of Lymphocyte-related Diseases And Conditions App 20180161359 - Mourich; Dan V. ; et al.	2018-06-14
Boronic acid conjugates of oligonucleotide analogues Grant 9,920,085 - Hanson March 20, 2	2018-03-20
Peptide oligonucleotide conjugates Grant 9,862,946 - Hanson January 9, 2	2018-01-09
Functionally-modified oligonucleotides and subunits thereof Grant 9,790,499 - Hanson , et al. October 17, 2	2017-10-17
Oligonucleotide Analogues Having Modified Intersubunit Linkages And/or Terminal Groups App 20170198287 - Hanson; Gunnar J. ; et al.	2017-07-13
Functionally-modified Oligonucleotides And Subunits Thereof App 20160376587 - Hanson; Gunnar J. ; et al.	2016-12-29
Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups Grant 9,469,664 - Hanson , et al. October 18, 2	2016-10-18
Peptide Oligonucleotide Conjugates App 20160237426 - Hanson; Gunnar J.	2016-08-18
Functionally-modified oligonucleotides and subunits thereof Grant 9,278,987 - Hanson , et al. March 8, 2	2016-03-08
Antisense modulation of interleukins 17 and 23 signaling Grant 9,238,042 - Schnell , et al. January 19, 2	2016-01-19
Peptide oligonucleotide conjugates Grant 9,161,948 - Hanson October 20, 2	2015-10-20
Compound And Method For Treating Myotonic Dystrophy App 20150141321 - Kole; Ryszard ; et al.	2015-05-21
Boronic Acid Conjugates Of Oligonucleotide Analogues App 20150080340 - Hanson; Gunnar J.	2015-03-19
Oligonucleotide Analogues Having Modified Intersubunit Linkages And/or Terminal Groups App 20150073140 - Hanson; Gunnar J. ; et al.	2015-03-12
Functionally-modified Oligonucleotides And Subunits Thereof App 20140330006 - Hanson; Gunnar J. ; et al.	2014-11-06
Oligonucleotides For Treating Expanded Repeat Diseases App 20140303238 - Linsley; Peter ; et al.	2014-10-09
Compound and method for treating myotonic dystrophy Grant 8,835,402 - Kole , et al. September 16, 2	2014-09-16
Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups Grant 8,779,128 - Hanson , et al. July 15, 2	2014-07-15
Compound And Method For Treating Myotonic Dystrophy App 20140107013 - Kole; Ryszard ; et al.	2014-04-17
Small molecule apoptosis promoters Grant 8,586,542 - Hanson , et al. November 19, 2	2013-11-19
Small Molecule Apoptosis Promoters App 20130281385 - Hanson; Gunnar J. ; et al.	2013-10-24
Peptide Oligonucleotide Conjugates App 20120289457 - Hanson; Gunnar J.	2012-11-15
Small molecule apoptosis promoters Grant 8,222,291 - Hanson , et al. July 17, 2	2012-07-17
Small molecule apoptosis promoters App 20120082640 - Hanson; Gunnar J. ; et al.	2012-04-05
Oligonucleotide Analogues Having Modified Intersubunit Linkages And/or Terminal Groups App 20120065169 - Hanson; Gunnar J. ; et al.	2012-03-15
Benzene, Pyridine, And Pyridazine Derivatives App 20110183977 - Huang; Kenneth He ; et al.	2011-07-28
Benzene, Pyridine, And Pyridazine Derivatives App 20110034529 - Huang; Kenneth He ; et al.	2011-02-10
Dimeric pyrrolidine amide-containing small molecule apoptosis promoters Grant 7,807,699 - Hanson , et al. October 5, 2	2010-10-05
Benzene, Pyridine, and Pyridazine Derivatives App 20090163493 - Huang; Kenneth He ; et al.	2009-06-25
Benzene, Pyridine, and Pyridazine Derivatives App 20080096887 - Huang; Kenneth He ; et al.	2008-04-24
Benzene, pyridine, and pyridazine derivatives Grant 7,358,370 - Huang , et al. April 15, 2	2008-04-15
Small molecule apoptosis promoters App 20080051389 - Hanson; Gunnar J. ; et al.	2008-02-28
2, 8-disubstituted Naphthyridine Derivatives App 20080032991 - Hanson; Gunnar J. ; et al.	2008-02-07
2,8-disubstituted naphthyridine derivatives Grant 7,282,506 - Hanson , et al. October 16, 2	2007-10-16
Cyclohexylamino Benzene, Pyridine, and Pyridazine Derivatives App 20070207984 - Huang; Kenneth He ; et al.	2007-09-06
Carbazole derivatives App 20070185184 - Hanson; Gunnar J. ; et al.	2007-08-09
Substituted pyrazolyl compounds for the treatment of inflammation Grant 7,211,597 - Metz , et al. May 1, 2	2007-05-01
Substituted pyrazoles as p38 kinase inhibitors App 20070078146 - Naraian; Ashok S. ; et al.	2007-04-05
Substituted pyrazolyl compounds for the treatment of inflammation Grant 7,186,743 - Bergmanis , et al. March 6, 2	2007-03-06
Substituted pyrazoles as p38 kinase inhibitors Grant 7,153,959 - Naraian , et al. December 26, 2	2006-12-26
Benzene, pyridine, and pyridazine derivatives App 20060211737 - Huang; Kenneth He ; et al.	2006-09-21
Substituted pyrazoles as p38 kinase inhibitors Grant 7,071,198 - Naraian , et al. July 4, 2	2006-07-04
Aromatic sulfone hydroxamic acid metalloprotease inhibitor App 20060084688 - Barta; Thomas E. ; et al.	2006-04-20
3 (5)-heteroaryl substituted pyrazoles as p38 kinase inhibitors Grant 7,019,005 - Naraian , et al. March 28, 2	2006-03-28
Methotrexate derivatives useful for treating cancer and arthritis App 20060035901 - Hanson; Gunnar J. ; et al.	2006-02-16
2,8-Disubstituted naphthyridine derivatives App 20060030584 - Hanson; Gunnar J. ; et al.	2006-02-09
Substituted pyrazoles as p38 kinase inhibitors Grant 6,979,686 - Naraian , et al. December 27, 2	2005-12-27
Substituted pyrazolyl compounds for the treatment of inflammation App 20050256180 - Bergmanis, Arija A. ; et al.	2005-11-17
Substituted pyrazolyl compounds for the treatment of inflammation Grant 6,956,052 - Bergmanis , et al. October 18, 2	2005-10-18
Substituted pyrazole urea compounds for the treatment of inflammation App 20050197338 - Huang, He ; et al.	2005-09-08
Aromatic sulfone hydroxamic acid metalloprotease inhibitor Grant 6,890,937 - Barta , et al. May 10, 2	2005-05-10
Amino diols useful in the treatment of alzheimer's disease App 20050080141 - Schostarez, Heinrich J. ; et al.	2005-04-14
Pyrazole derivatives as p38 kinase inhibitors Grant 6,852,740 - Hanson , et al. February 8, 2	2005-02-08
Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation Grant 6,849,653 - Clare , et al. February 1, 2	2005-02-01
Propargyl glycine amino propargyl diol compounds for treatment of hypertension App 20040220272 - Hanson, Gunnar J. ; et al.	2004-11-04
Pipecolic acid derivatives of proline threonine amides useful for the treatment of rheumatoid arthritis App 20040204367 - Hanson, Gunnar J.	2004-10-14
Alkylaminoalkyl-terminated sulfide/sulfonyl-containing propargyl amino-diol compounds for treatment of hypertension App 20040192780 - Hanson, Gunnar J.	2004-09-30
Substituted pyrazoles as p38 kinase inhibitors App 20040176433 - Naraian, Ashok S. ; et al.	2004-09-09
Use of propargyl glycine amino propargyl diol compounds for treatment of renal failure Grant 6,777,572 - Hanson , et al. August 17, 2	2004-08-17
3 (5) -heteroaryl substituted pyrazoles as p38 kinase inhibitors App 20040147579 - Naraian, Ashok S. ; et al.	2004-07-29
Substituted pyrazolyl compounds for the treatment of inflammation App 20040110741 - Bergmanis, Arija A. ; et al.	2004-06-10
Imidazolyl/benzimidazolyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension App 20040087801 - Hanson, Gunnar J. ; et al.	2004-05-06
Alkylaminoalkyl-terminated sulfide/sulfonyl-containing propargyl amino-diol compounds for treatment of hypertension App 20030236201 - Hanson, Gunnar J.	2003-12-25
Use of propargyl glycine amino propargyl diol compounds for treatment of congestive heart failure Grant 6,667,414 - Hanson , et al. December 23, 2	2003-12-23
Substituted pyrazoles as p38 kinase inhibitors Grant 6,617,324 - Naraian , et al. September 9, 2	2003-09-09
Pipecolic acid derivatives of proline threonine amides useful for the treatment of rheumatoid arthritis Grant 6,613,880 - Hanson September 2, 2	2003-09-02
Pyrazole derivatives as p38 kinase inhibitors App 20030144529 - Hanson, Gunnar J. ; et al.	2003-07-31
Use of propargyl glycine amino propargyl diol compounds for treatment of renal failure App 20030144542 - Hanson, Gunnar J. ; et al.	2003-07-31
Use of propargyl glycine amino propargyl diol compounds for treatment of congestive heart failure App 20030135066 - Hanson, Gunnar J. ; et al.	2003-07-17
Imidazolyl/benzimidazolyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension App 20030130329 - Hanson, Gunnar J. ; et al.	2003-07-10
Use of propargyl glycine amino propargyl diol compounds for prevention of hypertension App 20030130522 - Hanson, Gunnar J. ; et al.	2003-07-10
Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation App 20030125361 - Clare, Michael ; et al.	2003-07-03
Substituted pyrazolyl compounds for the treatment of inflammation App 20030114432 - Clare, Michael ; et al.	2003-06-19
3 (5)-heteroaryl substituted pyrazoles as p38 kinase inhibitors Grant 6,579,873 - Anantanarayan , et al. June 17, 2	2003-06-17
Substituted pyrazoles as p38 kinase inhibitors Grant 6,525,059 - Anantanarayan , et al. February 25, 2	2003-02-25
Substituted pyrazoles as p38 kinase inhibitors Grant 6,514,977 - Anantanarayan , et al. February 4, 2	2003-02-04
Pyrazole derivatives as p38 kinase inhibitors Grant 6,503,930 - Hanson , et al. January 7, 2	2003-01-07
Aromatic sulfone hydroxamic acid metalloprotease inhibitor App 20020177588 - Barta, Thomas E. ; et al.	2002-11-28
Imidazolyl/benzimidazolyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension App 20020115867 - Hanson, Gunnar J. ; et al.	2002-08-22
Substituted pyrazoles as p38 kinase inhibitors Grant 6,423,713 - Anantanarayan , et al. July 23, 2	2002-07-23
3 (5) -heteroaryl substituted pyrazoles as p38 kinase inhibitors App 20020086869 - Anantanarayan, Ashok ; et al.	2002-07-04
Ethynyl alanine amino diol compounds for treatment of hypertension App 20020025934 - Hanson, Gunnar J. ; et al.	2002-02-28
Use of propargyl glycine amino propargyl diol compounds for inhibiting plasma renin activity Grant 6,342,624 - Hanson , et al. January 29, 2	2002-01-29
Alkylaminoalkyl-terminated sulfide/sulfonyl-containing propargyl amino-diol compounds for treatment of hypertension App 20020010214 - Hanson, Gunnar J.	2002-01-24
Aromatic Sulfone Hydroxamic Acid Metalloprotease Inhibitor App 20010039287 - BARTA, THOMAS E ; et al.	2001-11-08
Pipecolic acid derivatives of proline threonine amides useful for the treatment of rheumatoid arthritis App 20010027247 - Hanson, Gunnar J.	2001-10-04
Aromatic Sulfone Hydroxamic Acid Metalloprotease Inhibitor App 20010014688 - BARTA, THOMAS E. ; et al.	2001-08-16
Alkylaminoalkyl-sulfonyl-terminated Beta-alanineamide amino-diol compounds for treatment of hypertension App 20010011101 - Hanson, Gunnar J. ; et al.	2001-08-02
Pyrazole derivatives as p38 kinase inhibitors Grant 6,087,381 - Hanson , et al. July 11, 2	2000-07-11
Substituted pyrazoles suitable as p38 kinase inhibitors Grant 6,087,496 - Anantanarayan , et al. July 11, 2	2000-07-11
3(5)-heteroaryl substituted pyrazoles as p38 kinase inhibitors Grant 5,932,576 - Anantanarayan , et al. August 3, 1	1999-08-03
Alkylaminoalkyl-terminated sulfide/sulfonyl-containing propargyl amino-diol compounds for treatment of hypertension Grant 5,488,067 - Hanson January 30, 1	1996-01-30
Propargyl glycine amino use of propargyl diol compounds for treatment of ophthalmic disorders Grant 5,484,812 - Hanson , et al. January 16, 1	1996-01-16
1,4-Thiomorpholino-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension Grant 5,411,959 - Hanson , et al. May 2, 1	1995-05-02
Piperidinyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension Grant 5,212,185 - Hanson May 18, 1	1993-05-18
Peptidyl beta-aminoacyl aminodiol carbamates as anti-hypertensive agents Grant 5,089,471 - Hanson , et al. February 18, 1	1992-02-18
.alpha.-aminoacyl .beta.-aminoacyl aminodiols as anti-hypertensive agents Grant 4,931,429 - Hanson , et al. June 5, 1	1990-06-05
Aminoalkylaminocarbonyl aminodiol amino acid derivatives as antihypertensive agents Grant 4,902,706 - Hanson , et al. February 20, 1	1990-02-20
Non-peptidyl beta-succinamidoacyl aminodiols as anti-hypertensive agents Grant 4,877,785 - Hanson , et al. October 31, 1	1989-10-31
N-(acyldipeptidyl)-aminoglycols Grant 4,657,931 - Baran , et al. April 14, 1	1987-04-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.